Weijing Sun
Professor, Medical Oncology · University of Kansas School of Medicine
Credentials: · · · · · ·
History
Research
JAMA Oncology · 2018 · 1,507 citations
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans
Science · 2011 · 1,398 citations
JAMA Oncology · 2019 · 630 citations
27 papers
25 papers
21 papers
17 papers
- BG
16 papers
- AS
15 papers
15 papers
10 papers
Grants
- 2003–2004
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $355 · University of Pennsylvania
Clinical trials
- 2018–2025
Principal investigator · Active not recruiting · Phase 2
University of Kansas Medical Center
- 2017–2019
Principal investigator · Withdrawn · Phase 2
Weijing Sun, MD, FACP
- 2009–2015
Phase II Study of Irinotecan and Panitumumab
Principal investigator · Completed · Phase 2
Weijing Sun, MD, FACP
- 2005–2010
Study chair · Completed · Phase 2
National Cancer Institute (NCI)